世界のハーセプチンバイオシミラー市場：専門的調査

• 英文タイトル：Global Herceptin Biosimilar Market Professional Survey Report 2019

• レポートコード：QYR9ST06057
• 出版社/出版日：QYResearch / 2019年9月2日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、102ページ
• 納品方法：Eメール（受注後2-3営業日）
• 産業分類：医薬品・医療

• 販売価格（消費税別）

Single User	￥518,000 (USD3,500)	▷ お問い合わせ
Enterprise License	￥1,036,000 (USD7,000)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

※本調査レポートは、ハーセプチンバイオシミラーの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、乳癌、大腸癌、白血病、リンパ腫、その他に、用途別には、病院及びクリニック、腫瘍センター、その他にセグメント区分し、ハーセプチンバイオシミラーの世界市場を分析しました。

・エグゼクティブ・サマリー
・ハーセプチンバイオシミラーの世界市場概要
・ハーセプチンバイオシミラーの製造コスト構成分析
・ハーセプチンバイオシミラーの開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・ハーセプチンバイオシミラーの地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・ハーセプチンバイオシミラーのセグメント分析（種類別）
（乳癌、大腸癌、白血病、リンパ腫、その他）
・ハーセプチンバイオシミラーのセグメント分析（用途別）
（病院及びクリニック、腫瘍センター、その他）
・ハーセプチンバイオシミラーの主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Amgen、AryoGen Biopharma、Biocon、Celltrion、Gedeon Richter、Genor Biopharma、Mabion、Mylan、Roche、The Instituto Vital Brazil）
・ハーセプチンバイオシミラーの市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...

Herceptin is the cancer medication used in the treatment of the breast cancer. It is monoclonal antibodies and are used along with the chemotherapy drugs. It is also termed as a targeted therapy drug. Trastuzumab is the one of the brand name herceptin which is administered by slow injection to a vein.
The global Herceptin Biosimilar market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Herceptin Biosimilar volume and value at global level, regional level and company level. From a global perspective, this report represents overall Herceptin Biosimilar market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Herceptin Biosimilar in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Herceptin Biosimilar manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Amgen
AryoGen Biopharma
Biocon
Celltrion
Gedeon Richter
Genor Biopharma
Mabion
Mylan
Roche
The Instituto Vital Brazil

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Breast Cancer
Colorectal Cancer
Leukemia
Lymphoma
Other

Segment by Application
Hospital & Clinics
Oncology Centers
Other

レポート目次

Table of Contents

Executive Summary
1 Industry Overview of Herceptin Biosimilar
1.1 Definition of Herceptin Biosimilar
1.2 Herceptin Biosimilar Segment by Type
1.2.1 Global Herceptin Biosimilar Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Breast Cancer
1.2.3 Colorectal Cancer
1.2.4 Leukemia
1.2.5 Lymphoma
1.2.6 Other
1.3 Herceptin Biosimilar Segment by Applications
1.3.1 Global Herceptin Biosimilar Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital & Clinics
1.3.3 Oncology Centers
1.3.4 Other
1.4 Global Herceptin Biosimilar Overall Market
1.4.1 Global Herceptin Biosimilar Revenue (2014-2025)
1.4.2 Global Herceptin Biosimilar Production (2014-2025)
1.4.3 North America Herceptin Biosimilar Status and Prospect (2014-2025)
1.4.4 Europe Herceptin Biosimilar Status and Prospect (2014-2025)
1.4.5 China Herceptin Biosimilar Status and Prospect (2014-2025)
1.4.6 Japan Herceptin Biosimilar Status and Prospect (2014-2025)
1.4.7 Southeast Asia Herceptin Biosimilar Status and Prospect (2014-2025)
1.4.8 India Herceptin Biosimilar Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Herceptin Biosimilar
2.3 Manufacturing Process Analysis of Herceptin Biosimilar
2.4 Industry Chain Structure of Herceptin Biosimilar

3 Development and Manufacturing Plants Analysis of Herceptin Biosimilar
3.1 Capacity and Commercial Production Date
3.2 Global Herceptin Biosimilar Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Herceptin Biosimilar
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Herceptin Biosimilar Production and Capacity Analysis
4.2 Herceptin Biosimilar Revenue Analysis
4.3 Herceptin Biosimilar Price Analysis
4.4 Market Concentration Degree

5 Herceptin Biosimilar Regional Market Analysis
5.1 Herceptin Biosimilar Production by Regions
5.1.1 Global Herceptin Biosimilar Production by Regions
5.1.2 Global Herceptin Biosimilar Revenue by Regions
5.2 Herceptin Biosimilar Consumption by Regions
5.3 North America Herceptin Biosimilar Market Analysis
5.3.1 North America Herceptin Biosimilar Production
5.3.2 North America Herceptin Biosimilar Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Herceptin Biosimilar Import and Export
5.4 Europe Herceptin Biosimilar Market Analysis
5.4.1 Europe Herceptin Biosimilar Production
5.4.2 Europe Herceptin Biosimilar Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Herceptin Biosimilar Import and Export
5.5 China Herceptin Biosimilar Market Analysis
5.5.1 China Herceptin Biosimilar Production
5.5.2 China Herceptin Biosimilar Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Herceptin Biosimilar Import and Export
5.6 Japan Herceptin Biosimilar Market Analysis
5.6.1 Japan Herceptin Biosimilar Production
5.6.2 Japan Herceptin Biosimilar Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Herceptin Biosimilar Import and Export
5.7 Southeast Asia Herceptin Biosimilar Market Analysis
5.7.1 Southeast Asia Herceptin Biosimilar Production
5.7.2 Southeast Asia Herceptin Biosimilar Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Herceptin Biosimilar Import and Export
5.8 India Herceptin Biosimilar Market Analysis
5.8.1 India Herceptin Biosimilar Production
5.8.2 India Herceptin Biosimilar Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Herceptin Biosimilar Import and Export

6 Herceptin Biosimilar Segment Market Analysis (by Type)
6.1 Global Herceptin Biosimilar Production by Type
6.2 Global Herceptin Biosimilar Revenue by Type
6.3 Herceptin Biosimilar Price by Type

7 Herceptin Biosimilar Segment Market Analysis (by Application)
7.1 Global Herceptin Biosimilar Consumption by Application
7.2 Global Herceptin Biosimilar Consumption Market Share by Application (2014-2019)

8 Herceptin Biosimilar Major Manufacturers Analysis
8.1 Amgen
8.1.1 Amgen Herceptin Biosimilar Production Sites and Area Served
8.1.2 Amgen Product Introduction, Application and Specification
8.1.3 Amgen Herceptin Biosimilar Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 AryoGen Biopharma
8.2.1 AryoGen Biopharma Herceptin Biosimilar Production Sites and Area Served
8.2.2 AryoGen Biopharma Product Introduction, Application and Specification
8.2.3 AryoGen Biopharma Herceptin Biosimilar Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Biocon
8.3.1 Biocon Herceptin Biosimilar Production Sites and Area Served
8.3.2 Biocon Product Introduction, Application and Specification
8.3.3 Biocon Herceptin Biosimilar Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Celltrion
8.4.1 Celltrion Herceptin Biosimilar Production Sites and Area Served
8.4.2 Celltrion Product Introduction, Application and Specification
8.4.3 Celltrion Herceptin Biosimilar Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Gedeon Richter
8.5.1 Gedeon Richter Herceptin Biosimilar Production Sites and Area Served
8.5.2 Gedeon Richter Product Introduction, Application and Specification
8.5.3 Gedeon Richter Herceptin Biosimilar Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Genor Biopharma
8.6.1 Genor Biopharma Herceptin Biosimilar Production Sites and Area Served
8.6.2 Genor Biopharma Product Introduction, Application and Specification
8.6.3 Genor Biopharma Herceptin Biosimilar Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Mabion
8.7.1 Mabion Herceptin Biosimilar Production Sites and Area Served
8.7.2 Mabion Product Introduction, Application and Specification
8.7.3 Mabion Herceptin Biosimilar Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Mylan
8.8.1 Mylan Herceptin Biosimilar Production Sites and Area Served
8.8.2 Mylan Product Introduction, Application and Specification
8.8.3 Mylan Herceptin Biosimilar Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Roche
8.9.1 Roche Herceptin Biosimilar Production Sites and Area Served
8.9.2 Roche Product Introduction, Application and Specification
8.9.3 Roche Herceptin Biosimilar Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 The Instituto Vital Brazil
8.10.1 The Instituto Vital Brazil Herceptin Biosimilar Production Sites and Area Served
8.10.2 The Instituto Vital Brazil Product Introduction, Application and Specification
8.10.3 The Instituto Vital Brazil Herceptin Biosimilar Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served

9 Development Trend of Analysis of Herceptin Biosimilar Market
9.1 Global Herceptin Biosimilar Market Trend Analysis
9.1.1 Global Herceptin Biosimilar Market Size (Volume and Value) Forecast 2019-2025
9.2 Herceptin Biosimilar Regional Market Trend
9.2.1 North America Herceptin Biosimilar Forecast 2019-2025
9.2.2 Europe Herceptin Biosimilar Forecast 2019-2025
9.2.3 China Herceptin Biosimilar Forecast 2019-2025
9.2.4 Japan Herceptin Biosimilar Forecast 2019-2025
9.2.5 Southeast Asia Herceptin Biosimilar Forecast 2019-2025
9.2.6 India Herceptin Biosimilar Forecast 2019-2025
9.3 Herceptin Biosimilar Market Trend (Product Type)
9.4 Herceptin Biosimilar Market Trend (Application)

10 Marketing Channel, Distributors and Customers
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Herceptin Biosimilar Distributors List
10.3 Herceptin Biosimilar Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Herceptin Biosimilar
Table Global Herceptin Biosimilar Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global Herceptin Biosimilar Production Market Share by Types in 2018
Figure Breast Cancer Product Picture
Figure Colorectal Cancer Product Picture
Figure Leukemia Product Picture
Figure Lymphoma Product Picture
Figure Other Product Picture
Table Global Herceptin Biosimilar Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global Herceptin Biosimilar Consumption Market Share by Applications in 2018
Figure Hospital & Clinics
Figure Oncology Centers
Figure Other
Figure Global Herceptin Biosimilar Revenue (Million USD) (2014-2025)
Figure Global Herceptin Biosimilar Production (K Units) (2014-2025)
Figure North America Herceptin Biosimilar Market Size (Million USD) (2014-2025)
Figure Europe Herceptin Biosimilar Market Size (Million USD) (2014-2025)
Figure China Herceptin Biosimilar Market Size (Million USD) (2014-2025)
Figure Japan Herceptin Biosimilar Market Size (Million USD) (2014-2025)
Figure Southeast Asia Herceptin Biosimilar Market Size (Million USD) (2014-2025)
Figure India Herceptin Biosimilar Market Size (Million USD) (2014-2025)
Table Herceptin Biosimilar Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Herceptin Biosimilar in 2018
Figure Manufacturing Process Analysis of Herceptin Biosimilar
Figure Industry Chain Structure of Herceptin Biosimilar
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Herceptin Biosimilar Manufacturing Plants Distribution
Table Herceptin Biosimilar Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Herceptin Biosimilar Capacity (K Units) of Major Manufacturers (2014-2019)
Table Herceptin Biosimilar Production (K Units) of Major Manufacturers (2014-2019)
Table Herceptin Biosimilar Production Market Share of Major Manufacturers (2014-2019)
Figure Herceptin Biosimilar Production Share by Manufacturers in 2018
Table Herceptin Biosimilar Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Herceptin Biosimilar Revenue Market Share of Major Manufacturers (2014-2019)
Figure Herceptin Biosimilar Revenue Share by Manufacturers in 2018
Table Herceptin Biosimilar Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Herceptin Biosimilar Production by Regions 2014-2019 (K Units)
Table Global Herceptin Biosimilar Production Market Share by Regions 2014-2019
Figure Global Herceptin Biosimilar Production Market Share by Regions in 2018
Table Global Herceptin Biosimilar Revenue by Regions 2014-2019 (Million USD)
Table Global Herceptin Biosimilar Revenue Market Share by Regions 2014-2019
Figure Global Herceptin Biosimilar Revenue Market Share by Regions in 2018
Table Global Herceptin Biosimilar Consumption by Regions 2014-2019 (K Units)
Table Global Herceptin Biosimilar Consumption Market Share by Regions 2014-2019
Figure North America Herceptin Biosimilar Production Growth Rate 2014-2019 (K Units)
Figure North America Herceptin Biosimilar Revenue Growth Rate 2014-2019 (Million USD)
Table North America Herceptin Biosimilar Production, Consumption Import and Export (K Units)
Figure Europe Herceptin Biosimilar Production Growth Rate 2014-2019 (K Units)
Figure Europe Herceptin Biosimilar Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Herceptin Biosimilar Production, Consumption Import and Export (K Units)
Figure China Herceptin Biosimilar Production Growth Rate 2014-2019 (K Units)
Figure China Herceptin Biosimilar Revenue Growth Rate 2014-2019 (Million USD)
Table China Herceptin Biosimilar Production, Consumption Import and Export (K Units)
Figure Japan Herceptin Biosimilar Production Growth Rate 2014-2019 (K Units)
Figure Japan Herceptin Biosimilar Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Herceptin Biosimilar Production, Consumption Import and Export (K Units)
Figure Southeast Asia Herceptin Biosimilar Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia Herceptin Biosimilar Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Herceptin Biosimilar Production, Consumption Import and Export (K Units)
Figure India Herceptin Biosimilar Production Growth Rate 2014-2019 (K Units)
Figure India Herceptin Biosimilar Revenue Growth Rate 2014-2019 (Million USD)
Table India Herceptin Biosimilar Production, Consumption Import and Export (K Units)
Figure Global Consumption Herceptin Biosimilar Market Share by Application (2014-2019)
Figure Global Value (Consumption) Herceptin Biosimilar Market Share by Application (2014-2019)
Table Amgen Herceptin Biosimilar Production Sites and Area Served
Table Amgen Herceptin Biosimilar Product Introduction, Application and Specification
Table Amgen Herceptin Biosimilar Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Amgen Herceptin Biosimilar Production Growth Rate (2014-2019)
Table Amgen Herceptin Biosimilar Production Market Share (2014-2019)
Figure Amgen Herceptin Biosimilar Revenue Market Share (2014-2019)
Table Amgen Herceptin Biosimilar Main Business and Markets Served
Table AryoGen Biopharma Herceptin Biosimilar Production Sites and Area Served
Table AryoGen Biopharma Herceptin Biosimilar Product Introduction, Application and Specification
Table AryoGen Biopharma Herceptin Biosimilar Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table AryoGen Biopharma Herceptin Biosimilar Production Growth Rate (2014-2019)
Table AryoGen Biopharma Herceptin Biosimilar Production Market Share (2014-2019)
Figure AryoGen Biopharma Herceptin Biosimilar Revenue Market Share (2014-2019)
Table AryoGen Biopharma Herceptin Biosimilar Main Business and Markets Served
Table Biocon Herceptin Biosimilar Production Sites and Area Served
Table Biocon Herceptin Biosimilar Product Introduction, Application and Specification
Table Biocon Herceptin Biosimilar Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Biocon Herceptin Biosimilar Production Growth Rate (2014-2019)
Table Biocon Herceptin Biosimilar Production Market Share (2014-2019)
Figure Biocon Herceptin Biosimilar Revenue Market Share (2014-2019)
Table Biocon Herceptin Biosimilar Main Business and Markets Served
Table Celltrion Herceptin Biosimilar Production Sites and Area Served
Table Celltrion Herceptin Biosimilar Product Introduction, Application and Specification
Table Celltrion Herceptin Biosimilar Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Celltrion Herceptin Biosimilar Production Growth Rate (2014-2019)
Table Celltrion Herceptin Biosimilar Production Market Share (2014-2019)
Figure Celltrion Herceptin Biosimilar Revenue Market Share (2014-2019)
Table Celltrion Herceptin Biosimilar Main Business and Markets Served
Table Gedeon Richter Herceptin Biosimilar Production Sites and Area Served
Table Gedeon Richter Herceptin Biosimilar Product Introduction, Application and Specification
Table Gedeon Richter Herceptin Biosimilar Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Gedeon Richter Herceptin Biosimilar Production Growth Rate (2014-2019)
Table Gedeon Richter Herceptin Biosimilar Production Market Share (2014-2019)
Figure Gedeon Richter Herceptin Biosimilar Revenue Market Share (2014-2019)
Table Gedeon Richter Herceptin Biosimilar Main Business and Markets Served
Table Genor Biopharma Herceptin Biosimilar Production Sites and Area Served
Table Genor Biopharma Herceptin Biosimilar Product Introduction, Application and Specification
Table Genor Biopharma Herceptin Biosimilar Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Genor Biopharma Herceptin Biosimilar Production Growth Rate (2014-2019)
Table Genor Biopharma Herceptin Biosimilar Production Market Share (2014-2019)
Figure Genor Biopharma Herceptin Biosimilar Revenue Market Share (2014-2019)
Table Genor Biopharma Herceptin Biosimilar Main Business and Markets Served
Table Mabion Herceptin Biosimilar Production Sites and Area Served
Table Mabion Herceptin Biosimilar Product Introduction, Application and Specification
Table Mabion Herceptin Biosimilar Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Mabion Herceptin Biosimilar Production Growth Rate (2014-2019)
Table Mabion Herceptin Biosimilar Production Market Share (2014-2019)
Figure Mabion Herceptin Biosimilar Revenue Market Share (2014-2019)
Table Mabion Herceptin Biosimilar Main Business and Markets Served
Table Mylan Herceptin Biosimilar Production Sites and Area Served
Table Mylan Herceptin Biosimilar Product Introduction, Application and Specification
Table Mylan Herceptin Biosimilar Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Mylan Herceptin Biosimilar Production Growth Rate (2014-2019)
Table Mylan Herceptin Biosimilar Production Market Share (2014-2019)
Figure Mylan Herceptin Biosimilar Revenue Market Share (2014-2019)
Table Mylan Herceptin Biosimilar Main Business and Markets Served
Table Roche Herceptin Biosimilar Production Sites and Area Served
Table Roche Herceptin Biosimilar Product Introduction, Application and Specification
Table Roche Herceptin Biosimilar Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Roche Herceptin Biosimilar Production Growth Rate (2014-2019)
Table Roche Herceptin Biosimilar Production Market Share (2014-2019)
Figure Roche Herceptin Biosimilar Revenue Market Share (2014-2019)
Table Roche Herceptin Biosimilar Main Business and Markets Served
Table The Instituto Vital Brazil Herceptin Biosimilar Production Sites and Area Served
Table The Instituto Vital Brazil Herceptin Biosimilar Product Introduction, Application and Specification
Table The Instituto Vital Brazil Herceptin Biosimilar Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table The Instituto Vital Brazil Herceptin Biosimilar Production Growth Rate (2014-2019)
Table The Instituto Vital Brazil Herceptin Biosimilar Production Market Share (2014-2019)
Figure The Instituto Vital Brazil Herceptin Biosimilar Revenue Market Share (2014-2019)
Table The Instituto Vital Brazil Herceptin Biosimilar Main Business and Markets Served
Figure Global Herceptin Biosimilar Production (K Units) Growth Rate Forecast 2019-2025
Figure Global Herceptin Biosimilar Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Herceptin Biosimilar Sales Price (USD/Unit) Forecast 2019-2025
Figure North America Herceptin Biosimilar Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America Herceptin Biosimilar Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Herceptin Biosimilar Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe Herceptin Biosimilar Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Herceptin Biosimilar Production Growth Rate Forecast 2019-2025 (K Units)
Figure China Herceptin Biosimilar Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Herceptin Biosimilar Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan Herceptin Biosimilar Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Herceptin Biosimilar Production Growth Rate Forecast 2019-2025 (K Units)
Figure Southeast Asia Herceptin Biosimilar Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Herceptin Biosimilar Production Growth Rate Forecast 2019-2025 (K Units)
Figure India Herceptin Biosimilar Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of Herceptin Biosimilar by Type (2019-2025)
Table Global Consumption (K Units) of Herceptin Biosimilar by Application (2019-2025)
Table Herceptin Biosimilar Distributors List
Table Herceptin Biosimilar Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介

世界のハーセプチンバイオシミラー市場：専門的調査

Global Herceptin Biosimilar Market Professional Survey Report 2019
QYR9ST06057 2019年9月2日 102Pages
※本調査レポートは、ハーセプチンバイオシミラーの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、乳癌、大腸癌、白血病、リンパ腫、その他に、用途別には、病院及びク...

バイオシミラーモノクローナル抗体の世界市場：市場規模・現状・予測

Global Biosimilar Monoclonal Antibody Market Size, Status and Forecast 2019-2025
QYR9ST03834 2019年9月2日 92Pages
※当調査レポートでは、バイオシミラーモノクローナル抗体の世界市場について調査・分析し、バイオシミラーモノクローナル抗体の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（合成化学、バイオ製薬、その他）、...

バイオシミラー試験・開発サービスの世界市場：市場規模・現状・予測

Global Biosimilar Testing and Development Services Market Size, Status and Forecast 2019-2025
QYR9ST04391 2019年9月2日 96Pages
※当調査レポートでは、バイオシミラー試験・開発サービスの世界市場について調査・分析し、バイオシミラー試験・開発サービスの世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（エフェクター結合、ELISA、速...

バイオシミラーの世界市場：インサイト・予測

Global Biosimilar Market Insights, Forecast to 2025
QYR9ST00380 2019年9月2日 113Pages
※本調査レポートでは、世界のバイオシミラー市場について調査・分析し、以下の構成でお届け致します。バイオシミラーの種類別には、人間用成長ホルモン、モノクローナル抗体、インスリン、ペプチド、エリスロポエチン、その他に、用途別には、腫瘍学、慢性および自己免疫疾患、成長ホルモン欠乏症、感染症、その他に、地域...

レミケードバイオシミラーの世界市場：インサイト・予測

Global Remicade Biosimilar Market Insights, Forecast to 2025
QYR9ST03014 2019年9月2日 114Pages
※本調査レポートでは、世界のレミケードバイオシミラー市場について調査・分析し、以下の構成でお届け致します。レミケードバイオシミラーの種類別には、100mg/10ml、500mg/50mlに、用途別には、血液疾患、腫瘍疾患に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド...

世界のバイオシミラーモノクローナル抗体市場：専門的調査

Global Biosimilar Monoclonal Antibodies Market Professional Survey Report 2019
QYR9ST07432 2019年9月5日 106Pages
※本調査レポートは、バイオシミラーモノクローナル抗体の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、インフリキシマブ、リツキシマブ、トラスツズマブ、アダリムマ...

世界のベーチェット病治療薬市場：専門的調査

Global Behcet Disease Drug Market Professional Survey Report 2019
QYR9ST14666 2019年9月10日 100Pages
※本調査レポートは、ベーチェット病治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、アダリムマブバイオシミラー、アプレミラスト、カナキヌマブ、インフリキシ...

次世代抗体療法の世界市場：市場規模・現状・予測

Global Next Generation Antibody Therapeutics Market Size, Status and Forecast 2019-2025
QYR9ST04976 2019年9月2日 90Pages
※当調査レポートでは、次世代抗体療法の世界市場について調査・分析し、次世代抗体療法の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（抗体薬物コンジュゲート（ADC）、二重特異性抗体（BsAbs）、Fc...

世界のTリンパ球活性化抗原CD80市場：専門的調査

Global T Lymphocyte Activation Antigen CD80 Market Professional Survey Report 2019
QYR9ST15170 2019年9月10日 100Pages
※本調査レポートは、Tリンパ球活性化抗原CD80の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、アバタセプト、アバタセプトバイオシミラー、CUE-201、KA...

スマートヘルスケアの世界市場：市場規模・現状・予測

Global Smart Healthcare Market Size, Status and Forecast 2019-2025
QYR9ST05037 2019年9月2日 92Pages
※当調査レポートでは、スマートヘルスケアの世界市場について調査・分析し、スマートヘルスケアの世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（スマートシリンジ、スマートピル、電子患者記録、スマートRFI...

世界のハーセプチンバイオシミラー市場：専門的調査 Herceptin is the cancer medication used in the treatment of the breast cancer. It is monoclonal antibodies and are used along with the chemotherapy drugs. It is also termed as a targeted therapy drug. Trastuzumab is the one of the brand name herceptin which is administered by slow injection to a vei…
バイオシミラーモノクローナル抗体の世界市場：市場規模・現状・予測 Biosimilar monoclonal antibodies (mAbs) are complex, large proteins of the biosimilar family used by the immune system to identify and neutralize foreign bodies, such as bacteria, viruses, and others. These antibodies are normally administered in the treatment of diseases such as rheumatoid arthriti…
バイオシミラー試験・開発サービスの世界市場：市場規模・現状・予測 The global biosimilar testing and development services is segmented on the basis of clinical assays, comparability testing, and region. On the basis of clinical assays, it is divided into PK assay, tiered immunogenicity testing, and NAb assays. On the basis of comparability testing, it is classified…
レミケードバイオシミラーの世界市場：インサイト・予測 Biosimilar can be defined as a type of biological product that is highly similar to an already FDA approved drug, known as reference biological product. The global Remicade Biosimilar market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx…
バイオシミラーの世界市場：インサイト・予測 A product is termed as biosimilar product, if it is a biological product with similar characteristics as that of a reference biological product, which possesses approval from agencies such as FDA. There would not be any major clinical difference in effectiveness and safety as that of reference produ…